genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Bioprocessing
Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility
Infectious Diseases
Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children
Antibodies
Broad Range Antibodies Neutralize All SARS-CoV-2 Variants and Other Coronaviruses
Mitochondrial Diseases
Novel Insights into the Organization of Proteins in Mitochondria
Animal Models
Prairie Vole Study Raises Questions on Role of Oxytocin in Social…
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Companies
Companies
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Infectious Diseases
StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
miRNA
AbbVie to Develop mRNA Modulators Using Anima Biotech Platform
Financing
StockWatch: Shares Double for Targets of 3 Buyout Deals Announced at JPM
Whole-Genome Analysis
At JPM, Illumina Announces African-American Sequencing Collaboration
Oncologics
Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment
Blood Disorders
Rising Star: Vega Targets Rare Blood Disorders with Antibodies
Antibodies
Absci Pursues Google-Sized Ambitions in Drug Discovery, Manufacturing
Cancer
StockWatch: Moderna Cancer Vaccine Propels 72% Surge
Autoimmune Disorders
Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B
Rare and Neglected Diseases
Amgen to Acquire Horizon for $27.8B, Expanding Rare Disease Pipeline
CAR T-Cells
Kite Inks Up-to-$4B Deal to Co-Develop Arcellx Myeloma CAR T-Cell Therapy
Lung Cancer
StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso
Companies
Which Artificial Intelligence System Works Best for You?
Immunology
StockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi
Cell Therapy
AstraZeneca Acquires Neogene, Expanding in Cancer Cell Therapy
1
2
3
...
69
Page 1 of 69
Scroll Up
Login
Subscribe